Life360 Inc SEC Filings

Charles J. Prober, a director of Life360, Inc. (LIF), reported transactions on 09/15/2025 conducted under a Rule 10b5-1 trading plan. The Form 4 shows an acquisition of 7,930 shares via exercise of stock options at an $11.18 exercise price and a contemporaneous sale of 7,930 shares at $100.24 per share. After the transactions the reporting person’s direct beneficial ownership is reported as 105,456 shares in one line and 111,020 options-related shares in the derivative table; the filing also notes total holdings include 2,036 restricted stock units that convert to common stock upon vesting. The Form 4 states the 10b5-1 plan was adopted on March 14, 2025, and the option vesting schedule is described in the filing.

Life360, Inc. submitted a Rule 144 notice proposing the sale of 7,930 common shares through Fidelity Brokerage Services on 09/15/2025 with an aggregate market value of $794,903.20. The filing reports 77,548,651 shares outstanding. The securities were acquired on 09/15/2025 as options originally granted on 04/12/2022 and the stated payment method is cash. The form also discloses two prior sales by Charles Prober within the past three months: 7,930 shares sold on 07/14/2025 for $510,771.30 and 7,930 shares sold on 08/13/2025 for $667,150.90. The filer attests there is no undisclosed material adverse information.

Chris Hulls, a director of Life360, Inc. (LIF), reports a non‑market transaction on 09/04/2025 in which 7,152 shares of common stock were withheld by the issuer at a per‑share price of $86.65 to satisfy income tax withholding related to the vesting and net settlement of previously reported restricted stock units. After this withholding, the Reporting Person beneficially owns 476,678 shares (this total includes common stock and shares underlying CDIs converted on a 1:3 common stock to CDI ratio). The filing notes 137,853 restricted stock units previously granted and identifies holdings reported indirectly: 195,312 shares held by each of three named irrevocable trusts and 1,846 shares representing the Reporting Person’s proportionate interest in ICCA Labs, LLC. The Form 4 was signed by an attorney‑in‑fact on 09/08/2025.

Life360, Inc. (LIF) insider transaction summary: Chief Executive Officer and Director Lauren Antonoff sold 17,764 shares of Life360 common stock on 09/05/2025 at an average reported price of $90.903 per share. The Form 4 states the sale was a "sell-to-cover" to satisfy tax withholding obligations tied to the vesting and settlement of previously granted restricted stock units (RSUs). After the transaction Antonoff beneficially owned 338,465 shares, which the filing notes includes 222,277 unvested RSUs that convert to one share each upon vesting. The Form 4 was signed by an attorney-in-fact on 09/08/2025.

Life360, Inc. insider transaction by CFO John Burke: On 09/04/2025 the reporting person, John Burke (Chief Financial Officer), had 9,976 shares withheld at a price of $86.65 to satisfy income tax withholding in connection with the vesting and net settlement of previously granted restricted stock units. After this withholding, the filing shows Mr. Burke beneficially owns 101,255 shares directly and 63,030 shares indirectly (held by the Russell John Burke Revocable Trust). The form notes there are 91,732 restricted stock units previously granted that represent contingent rights to receive common stock upon vesting.

Form 144 filed for Life360, Inc. (LIF) reporting a proposed sale of 17,764 common shares through Fidelity Brokerage Services with an aggregate market value of $1,614,806.22, and an approximate sale date of 09/05/2025 on NASDAQ. The filing states these shares were acquired by restricted stock vesting from the issuer and that payment is compensation. The filing also discloses four prior dispositions by the same seller in the past three months totaling 32,446 shares for gross proceeds of $2,252,183.02. The notice includes the seller's representation that they are not aware of any undisclosed material adverse information.

Life360 director John Philip Coghlan reported sales of common stock under a Rule 10b5-1 plan on 09/02/2025. The Form 4 shows two reported sale groupings: 508 shares sold at a weighted average price of $87.03 (individual trades ranged $86.50–$87.49) and 2,617 shares sold at a weighted average price of $88.33 (individual trades ranged $87.74–$88.71).

After these transactions the reporting person beneficially owned 11,992 shares held by the John Coghlan Living Trust and 9,375 shares held by the same trust, plus 67,604 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. The filings note 3,344 restricted stock units that convert to shares upon vesting. The sales were effected pursuant to a 10b5-1 plan adopted December 6, 2024.

Life360, Inc. reporting person Lauren Antonoff, who serves as Chief Executive Officer and a director, received a grant of 52,997 restricted stock units (RSUs) on 09/01/2025. Each RSU converts to one share upon settlement and the grant vests monthly at a rate of 1/48th beginning September 1, 2025, subject to continued service. Following the grant, the filing reports 356,229 shares/RSU-equivalents beneficially owned, which includes 258,971 previously granted RSUs. The acquisition was recorded at a $0 price (typical for RSU grants). The Form 4 was signed by an attorney-in-fact on 09/03/2025.

Life360 director Chris Hulls received a grant of 26,499 restricted stock units (RSUs) that vest monthly over four years. Each RSU converts into one share upon settlement and 1/48th vests monthly beginning 09/01/2025, subject to continuous service. After the grant the reporting person beneficially owns 483,830 shares (including previously granted RSUs).

The filing discloses 151,934 previously granted RSUs, ownership through three family irrevocable trusts and a minority interest in ICCA Labs, LLC, and that 585,938 CDIs remain subject to a lock-up agreement.